Search results

1. System engineering approach to modeling, analysis and prediction of outcome of combined anticancer therapies

Principal investigator: prof. Andrzej Świerniak

Politechnika Śląska, Wydział Automatyki, Elektroniki i Informatyki

Call: OPUS 11, Panel: ST7

2. Development of optimization methods for dose selection of analgesic drugs used as a combination drug therapy in neuropat…

Principal investigator: dr hab. Kinga Sałat

Uniwersytet Jagielloński- Collegium Medicum, Uniwersytet Jagielloński - Collegium Medicum; Wydział Farmaceutyczny

Call: OPUS 9, Panel: NZ7

3. Combination therapy with naphthoquinones and paclitaxel in the pharmacological induction of cell death in breast cancer …

Principal investigator: dr Anna Kawiak

Uniwersytet Gdański

Call: OPUS 2, Panel: NZ7

4. Hybrid Nanocomposites Based on Gold Nanoparticles as Promising Photoactive Materials for Combined Photothermal/Photodyna…

Principal investigator: dr Paulina Błaszkiewicz

Uniwersytet im. Adama Mickiewicza w Poznaniu, Centrum NanoBioMedyczne

Call: SONATINA 7, Panel: ST4

5. Bioresorbable, electrospun nonwoven as a multi-drug delivery system for a combination glioblastoma therapy

Principal investigator: dr Monika Anna Musiał-Kulik

Centrum Materiałów Polimerowych i Węglowych PAN

Call: SONATA 17, Panel: NZ7

6. Photodynamic therapy combined with PD-1/PD-L1 blockade immunotherapy: new possibilities for the treatment of immunogenic…

Principal investigator: dr hab. Janusz Marcin Dąbrowski

Uniwersytet Jagielloński, Wydział Chemii

Call: OPUS 19, Panel: NZ7

7. STING protein activation combined with anti-vascular agent as a novel strategy for anticancer therapy

Principal investigator: dr hab. Ryszard Smolarczyk

Centrum Onkologii - Instytut im. Marii Skłodowskiej-Curie, Oddział w Gliwicach

Call: OPUS 16, Panel: NZ5

8. Oral endoglin based-DNA vaccine combined with gene encoding IL-12 can polarize tumor microenvironment from proangiogenic…

Principal investigator: dr Magdalena Jarosz-Biej

Centrum Onkologii - Instytut im. Marii Skłodowskiej-Curie, Oddział w Gliwicach

Call: OPUS 6, Panel: NZ4

9. Combined targeted therapy with the use of PPAR receptor ligands or statins and cytostatics aimed at molecular mechanisms…

Principal investigator: dr Wojciech Stanisław Placha

Uniwersytet Jagielloński- Collegium Medicum, Collegium Medicum; Wydział Lekarski

Call: SONATA 1, Panel: NZ4

10. Nature-inspired conductive and bioadhesive kirigami-based nanoarchitectured cardiac patch for combined chemo- and stem c…

Principal investigator: dr hab. Filippo Pierini

Instytut Podstawowych Problemów Techniki Polska Akademia Nauk

Call: OPUS 26, Panel: ST5

11. Novel combination therapies of pulmonary arterial hypertension targeting blockade of peripheral cannabinoid CB1 receptor…

Principal investigator: prof. Barbara Malinowska

Uniwersytet Medyczny w Białymstoku

Call: OPUS 21, Panel: NZ7

12. Genetically modified dendritic cells as a component of combined therapy immunomodulating the tumor microenvironment

Principal investigator: dr hab. Elżbieta Pajtasz-Piasecka

Instytut Immunologii i Terapii Doświadczalnej im. Ludwika Hirszfelda Polskiej Akademii Nauk

Call: OPUS 14, Panel: NZ6

13. Co-delivery drug systems based on ionic graft polymers carrying pharmaceutical anions with antibacterial activities for …

Principal investigator: prof. Dorota Neugebauer

Politechnika Śląska, Wydział Chemiczny

Call: OPUS 14, Panel: ST5

14. Combined urinary bladder cancer treatment with isothiocyanate-derived mercapturic acids and microtubule assembly modulat…

Principal investigator: dr Mateusz Psurski

Instytut Immunologii i Terapii Doświadczalnej im. Ludwika Hirszfelda Polskiej Akademii Nauk

Call: SONATA 13, Panel: NZ7

15. Assessment of virulence, biofilm formation and drug-susceptibility of Candida albicans treated with plant essential oils…

Principal investigator: Aleksandra Budzyńska

Uniwersytet Łódzki, Wydział Biologii i Ochrony Środowiska

Call: PRELUDIUM 1, Panel: NZ6

16. New, multifunctional nanoparticles for combined photothermal and gene silencing cancer therapy

Principal investigator: prof. Stefan Jurga

Uniwersytet im. Adama Mickiewicza w Poznaniu, Centrum Nanobiomedyczne

Call: OPUS 11, Panel: ST8

17. Combined induction of cell death of canine leukemia and lymphoma.

Principal investigator: dr hab. Andrzej Marek Rapak

Instytut Immunologii i Terapii Doświadczalnej im. Ludwika Hirszfelda Polskiej Akademii Nauk

Call: OPUS 2, Panel: NZ5

18. The study on the mechanism of vitamin D analogues anticancer action in combination with anastrozole in a human breast ca…

Principal investigator: Beata Filip-Psurska

Instytut Immunologii i Terapii Doświadczalnej im. Ludwika Hirszfelda Polskiej Akademii Nauk

Call: PRELUDIUM 3, Panel: NZ4

19. The study of mechanisms that enhance the antitumor activity of 5-FU by the use of vitamin D analogs in human colon cance…

Principal investigator: dr Magdalena Milczarek

Instytut Immunologii i Terapii Doświadczalnej im. Ludwika Hirszfelda Polskiej Akademii Nauk

Call: PRELUDIUM 3, Panel: NZ5

20. Characterization of anticancer activity of new synthetic alpha-methylene-delta lactones in cancer cell lines.

Principal investigator: dr hab. Katarzyna Anna Gach-Janczak

Uniwersytet Medyczny w Łodzi, Wydział Lekarski

Call: SONATA 9, Panel: NZ3

21. Phytoecdysteroids as a potential drugs inhibiting Toxoplasma gondii invasion

Principal investigator: dr Katarzyna Monika Dzitko

Uniwersytet Łódzki, Wydział Biologii i Ochrony Środowiska

Call: OPUS 1, Panel: NZ6

Projects search